Revelation Biosciences On Track for End-of-Phase 1 Meeting With FDA Later This Year
SAN DIEGO, CA / ACCESS Newswire / November 20, 2025 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a...
Brain
Revelation Biosciences On Track for End-of-Phase 1 Meeting With FDA Later This Year
SAN DIEGO, CA / ACCESS Newswire / November 20, 2025 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a...
Nasus Pharma Strengthens Leadership Team, Appointing Eyal Rubin as Executive Vice President and Chief Financial Officer
Veteran CFO appointment underscores the Company’s commitment to building a strong leadership team as it advances its clinical and commercial...
Biogen to Highlight New Lecanemab Data and Scientific Advances at the 18th Clinical Trials on Alzheimer’s Disease Conference
New lecanemab findings highlight the safety and potential benefits of subcutaneous administration for initiation dosing, the potential for additional long-term...
Axsome Therapeutics to Participate in Upcoming Investor Conferences
NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era...
Gain Therapeutics Presents Preclinical GT-02287 Data at Neuroscience 2025
GT-02287 reduces mitochondrial stress and enhances neuronal survival in MPP+ treated rat dopaminergic neurons GT-02287 decreases staining for MIRO1, suggesting...
10k Science, an NIH-funded platform for science education, launches a new VR experience on UC Davis research into non-opioid pain relief
OAKLAND, Calif., Nov. 19, 2025 /PRNewswire/ -- Today, educational software company Dynamoid announced the launch of the 10k Science immersive 3D...
Best Tasting Protein Shake (2025): Ka’Chava Named Favorite Nutritional Shake by Expert Consumers
NEW YORK, Nov. 19, 2025 /PRNewswire/ -- Expert Consumers has named Ka'Chava as the top tasting protein shake of 2025,...
Seedtag Releases First-of-Its-Kind Neuroscience Study Redefining Human-Centered Advertising Effectiveness
Brain activity study shows Neuro-Contextual advertising drives 3.5x higher neural engagement and 26% lift in positive, action-driving response NEW YORK,...
The Rise of Advanced Maternal Age IVF: BaseCare Medical’-B(2170.HK) AI “Undisturbed Culture” Empowers Intelligent Assisted Reproduction
SUZHOU, China, Nov. 19, 2025 /PRNewswire/ -- Data from the keynote report at the 18th Annual Conference of the Chinese...
ADIA Nutrition Inc. to Host Webinar on HSCT for MS and Autoimmune Conditions with HSCT Warriors
Winter Park, Florida--(Newsfile Corp. - November 19, 2025) - ADIA Nutrition, Inc. (OTCQB: ADIA) invites all shareholders, supporters, and potential...
Philips and Cortechs.ai extend partnership to advance quantitative neuroimaging and strengthen Philips’ leadership in precision diagnostics in neurology
Clinician views Cortechs.ai neuroimaging analytics Clinician views Cortechs.ai neuroimaging analytics November 19, 2025Amsterdam, the Netherlands – Royal Philips (NYSE: PHG,...
Beacon Biosignals Announces Multi-Year Expansion of Strategic Collaboration with Takeda to Advance Narcolepsy Diagnosis and Neurobiomarker Discovery
BOSTON, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Beacon Biosignals, a leading neurotechnology company powering AI-driven neurodiagnostics and precision medicines for...
Solana Company Reports Third Quarter 2025 Financial Results
NEWTOWN, Pa., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ: HSDT) (the “Company” or “HSDT”), a publicly listed company...
Hemostemix Closes CDN$280,594 Private Placement
Calgary, Alberta--(Newsfile Corp. - November 18, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company"),...
Linus Health Highlights AI-Enabled Solutions Advancing Early Alzheimer’s Detection and Clinical Trial Readiness at CTAD 2025
BOSTON, Nov. 18, 2025 /PRNewswire/ -- Linus Health, an AI-driven brain health company pioneering early detection of cognitive impairment and...
A First-of-Its-Kind, Formula-Free Guide to AI and Machine Learning for Decision Makers, by Corina J. Shtir, PhD
SAN DIEGO, Nov. 18, 2025 /PRNewswire/ -- AI and Machine Learning Unpacked: A Practical Guide for Decision Makers in Life Sciences...
Nexalin’s 15 Milliamp Neurostimulation Device Demonstrates Promising Results in Treating Gambling Disorder with Alcohol Use Comorbidity
Peer-reviewed case report published in The American Journal on Addictions highlights significant clinical improvement and sustained abstinence following Nexalin’s non-invasive...
Radiopharm Theranostics Receives Approval to Initiate Phase 1 Therapeutic Trial of RAD 402 (KLK3-mAb with Tb161) in Advanced Prostate Cancer
RAD 402 is a humanized IgG1 internalized by prostate cells, binding KLK3 with high affinity Tb-161 antitumor activity driven by...
Synergy CHC Corp. (NASDAQ: SNYR) Adds Five New Direct Store Delivery Partners, Expanding FOCUSfactor Functional Beverage Distribution to Ten States Nationwide
WESTBROOK, Maine, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a leading consumer...